Drawing comparisons — How studying one ailment may solve another

Researchers are studying Chikungunya arthritis in hopes it will lead to treatments for patients suffering from rheumatoid arthritis, according to WNDU.com.

Advertisement

Here are four points:

1. By studying Chikungunya arthritis, researchers can learn more about the immunological mechanisms driving joint inflammation.

2. Researchers are comparing the white blood cells between Chikungunya patients and rheumatoid arthritis patients.

3. Both conditions lead to morning stiffness primarily affecting the joints in the hands, wrists, feet and ankles.

4. While Chikungunya can be cured, rheumatoid arthritis can only be treated.

More articles on quality & infection control:
Phoenix nonprofit receives $3.6M federal grant for healthcare improvement: 5 notes
Making varsity: Indiana University coaching physicians to improve care with $46M grant
CDC & FDA issues alert to healthcare facilities — 4 notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.